Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
acute myeloid leukemia
Pharma
Daiichi Sankyo, Glenmark, Serum-Biocon—Fierce Pharma Asia
Daiichi tripled Enhertu sales in its last fiscal year but had its leukemia drug delayed at the FDA. Glenmark settled an antitrust lawsuit. Plus more.
Angus Liu
Apr 28, 2023 8:35am
Daiichi-Seagen, Roche-Jemincare, AbbVie-I-Mab—Fierce Pharma Asia
Aug 19, 2022 9:35am
Daiichi, BeiGene, Kyowa Kirin—Fierce Pharma Asia
Jun 17, 2022 10:15am
Sevier's Tibsovo gets FDA nod in combo with BMS' Vidaza in AML
May 26, 2022 10:02am
Merck-Eisai, J&J-Legend, AZ-Samsung and more—Fierce Pharma Asia
Dec 17, 2021 10:20am
Astellas finds the silver lining in failed trial for Xospata
Dec 14, 2021 2:57am
